Skip to main content
Premium Trial:

Request an Annual Quote

Tadd Lazarus

Clinical Genomics has appointed Tadd Lazarus as chief medical officer. Lazarus most recently served as senior vice president and chief medical officer for Luminex. He also served as chief medical officer and head of medical and scientific affairs, reimbursement, and public policy at Qiagen from 2013 to 2016. Lazarus also was previously employed by Gen-Probe (now Hologic) as chief medical officer and VP of clinical affairs. He began his career at Roche Diagnostics, where he held simultaneous roles in private practice and as director of medical and scientific affairs, and then as the North American medical director for the molecular diagnostics, POC, diabetes, clinical chemistry, and immunology businesses.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.